PGR and neoplasm: The expression of hormonal receptors including estrogen receptors (ER), and progesterone receptors (PR), and the absence or presence of human epidermal growth factor 2 (HER2) receptors, known as luminal A or B subtypes, in the tumor tissue determine the suitability of the patient for hormonal or targeted therapy.